BE Pharmaceuticals
BE Pharmaceuticals is a US-based expansion of Biological E. Limited, a family-owned company with over 60 years of experience in sterile vaccine and injectable product manufacturing. Located in Cary, North Carolina, it commenced operations in October 2019, offering a range of products including liquid vials, lyophilized products, and pre-filled syringes. The company is engaged in developing over 20 products and aims to introduce 5-7 new products annually. It supplies a broad customer base across all 50 states and Puerto Rico, including pharmacies, hospitals, long-term care facilities, and infusion centers. As part of its parent company, Biological E., it has a global presence in vaccine manufacturing, working with organizations like UNICEF, PAHO, and The Gates Foundation, and has supplied over 2 billion vaccine doses in the last decade.
Industries
Nr. of Employees
small (1-50)
BE Pharmaceuticals
Cary, North Carolina, United States, North America
Products
Carboprost tromethamine injection
Injectable prostaglandin analogue indicated for obstetric use (as provided on product listing).
Daptomycin for injection
Injectable antibiotic indicated for treatment of complicated skin and skin-structure infections caused by susceptible Gram-positive bacteria.
Enoxaparin sodium injection
Low-molecular-weight heparin injectable available in multiple strengths for anticoagulation therapy; in-house API manufacture cited for this product.
Fosaprepitant for injection
Injectable antiemetic used in combination with other agents for prevention of acute and delayed nausea and vomiting associated with emetogenic chemotherapy.
Glycopyrrolate injection
Injectable anticholinergic indicated for reduction of saliva and secretion control and other clinical uses per product labeling.
Heparin sodium injection
Unfractionated heparin injectable available in multiple unit strengths for anticoagulation therapy; mechanism: multiple anticoagulant activities in coagulation cascade.
Carboprost tromethamine injection
Injectable prostaglandin analogue indicated for obstetric use (as provided on product listing).
Daptomycin for injection
Injectable antibiotic indicated for treatment of complicated skin and skin-structure infections caused by susceptible Gram-positive bacteria.
Enoxaparin sodium injection
Low-molecular-weight heparin injectable available in multiple strengths for anticoagulation therapy; in-house API manufacture cited for this product.
Fosaprepitant for injection
Injectable antiemetic used in combination with other agents for prevention of acute and delayed nausea and vomiting associated with emetogenic chemotherapy.
Glycopyrrolate injection
Injectable anticholinergic indicated for reduction of saliva and secretion control and other clinical uses per product labeling.
Heparin sodium injection
Unfractionated heparin injectable available in multiple unit strengths for anticoagulation therapy; mechanism: multiple anticoagulant activities in coagulation cascade.
Services
Distribution of injectable and vaccine products across all US states and territories via logistics partners, wholesalers, and distributor networks.
US-based sales, order management, customer service, finance and EDI support for marketed injectable products.
Distribution of injectable and vaccine products across all US states and territories via logistics partners, wholesalers, and distributor networks.
US-based sales, order management, customer service, finance and EDI support for marketed injectable products.
Expertise Areas
- Sterile injectable manufacturing
- Large-scale vaccine manufacturing and supply
- Specialty generic injectables and NBCD development
- Synthetic biology for API production
Key Technologies
- Lyophilization (freeze-drying)
- Prefilled syringe fill-finish
- Vial filling and sterile liquid fill-finish
- Synthetic biology-based API production
News & Updates
BE Pharmaceuticals has partnered with Ohio State University and Baylor College of Medicine to develop and expand its vaccine pipeline.
Biological E acquired Akorn India to expand its manufacturing capabilities.
Biological E is manufacturing a substance used in Johnson & Johnson's potential COVID-19 vaccine.
An article in The Guardian discussing Biological E's role in producing the Corbevax COVID-19 vaccine.
The White House announced support through DFC to help finance Biological E Ltd.'s efforts in COVID-19 vaccine manufacturing.
Reuters reports on Biological E's plans to produce a large volume of Johnson & Johnson's COVID-19 vaccine.
BE Pharmaceuticals has partnered with Ohio State University and Baylor College of Medicine to develop and expand its vaccine pipeline.
Biological E acquired Akorn India to expand its manufacturing capabilities.
Biological E is manufacturing a substance used in Johnson & Johnson's potential COVID-19 vaccine.
An article in The Guardian discussing Biological E's role in producing the Corbevax COVID-19 vaccine.
The White House announced support through DFC to help finance Biological E Ltd.'s efforts in COVID-19 vaccine manufacturing.
Reuters reports on Biological E's plans to produce a large volume of Johnson & Johnson's COVID-19 vaccine.